F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boomnews2026-07-24T21:15:21+00:00July 24th, 2026|The New York Times|
Two Telehealth Executives Sentenced for Scheme to Distribute Adderallnews2026-07-09T22:18:14+00:00July 9th, 2026|The New York Times|
Supreme Court Allows Abortion Pill Access by Mail to Continuenews2026-05-14T22:51:53+00:00May 14th, 2026|The New York Times|
Supreme Court Continues Access to Abortion Pill by Mail, for a Few Daysnews2026-05-11T20:03:14+00:00May 11th, 2026|The New York Times|
Supreme Court Asked to Restore Access to Abortion Pill by Mailnews2026-05-02T23:16:52+00:00May 2nd, 2026|The New York Times|
GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Upnews2026-04-15T21:43:41+00:00April 15th, 2026|The New York Times|
How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Companynews2026-04-02T09:02:30+00:00April 2nd, 2026|The New York Times|
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertisernews2025-09-12T22:09:11+00:00September 12th, 2025|The New York Times|
California Passes Bill Allowing Omission of Patients’ Names From Abortion Pill Bottlesnews2025-09-11T17:21:43+00:00September 11th, 2025|The New York Times|
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycatsnews2025-04-16T14:43:02+00:00April 16th, 2025|The New York Times|
